Nahid Khodakarami

Nahid Khodakarami


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2011 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
NKNahid Khodakarami
Nahid Khodakarami
GCGary M. Clifford
Gary M. Clifford
PYParvin Yavari
Parvin Yavari
FFFarah Farzaneh
Farah Farzaneh
SSSaghar Salehpour
Saghar Salehpour
SFSilvia Franceschi
Silvia Franceschi
No data exist on the population prevalence of, or risk factors for, human papillomavirus (HPV) infection in Iran or the Middle East. Cervical specimens were obtained from 825 married women aged 18–59 years from the general population of Tehran, Iran and from 45 locally diagnosed invasive cervical cancers (ICC) according to the standardized protocol of the International Agency for Research on Cancer HPV Prevalence Surveys. HPV was detected and genotyped using a GP5+/6+ PCR‐based assay. HPV prevalence in the general population was 7.8% (95% confidence interval: 6.0–9.8) (5.1% of high‐risk types), with no significant variation by age. HPV positivity was significantly higher among divorced women, women in polygamous marriages and those reporting husband's absence from home for >7 nights/month. HPV16/18 accounted for 30 and 82.2% of HPV‐positive women in the general population and ICC, respectively. Cervical cancer prevention policies should take into account the relatively low HPV prevalence in this population.

10 September 2009 in Journal of Midwifery & Women's Health
Verified
Journal Article
Closed access
NKNahid Khodakarami
Nahid Khodakarami
MFMoatar Fariborz
Moatar Fariborz
GAGhahiri Ataolah
Ghahiri Ataolah
SSShahdan Solokian
Shahdan Solokian

22 November 2015 in International Journal of Health Policy and Management
Verified
Journal Article
Open access
PDF file
AMAzam Majidi
Azam Majidi
RGReza Ghiasvand
Reza Ghiasvand
MHMaryam Hadji
Maryam Hadji
ANAzin Nahvijou
Azin Nahvijou
AMAzam-Sadat Mousavi
Azam-Sadat Mousavi
KZKazem Zendehdel
Kazem Zendehdel
Background Cervical cancer is the fourth most common cancer among women worldwide. Organized cervical screening and vaccination against human papilloma virus (HPV) have been successful interventions for prevention of invasive cervical cancer (ICC). Because of cultural and religious considerations, ICC has low incidence in Iran and many other Muslim countries. There is no organized cervical screening in these countries. Therefore, ICC is usually diagnosed in advanced stages with poor prognosis in these countries. We performed a priority setting exercise and suggested priorities for prevention of ICC in this setting. Methods We invited experts and researchers to a workshop and asked them to list important suggestions for ICC prevention in Iran. After merging similar items and removing the duplicates, we asked the experts to rank the list of suggested items. We used a strategy grid and Go-zone analysis to determine final list of priorities for ICC prevention in Iran. Results From 26 final items suggested as priorities for prevention of ICC, the most important priorities were developing national guidelines for cervical screening and quality control protocol for patient follow-up and management of precancerous lesions. In addition, we emphasized considering insurance coverage for cervical screening, public awareness, and research priorities, and establishment of a cervical screening registry. Conclusion A comprehensive approach and implementation of organized cervical screening program is necessary for prevention of ICC in Iran and other low incidence Muslim countries. Because of high cost for vaccination and low incidence of cervical cancer, we do not recommend HPV vaccination for the time being in Iran.

22 November 2023 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
RGRoya Gholami
Roya Gholami
NBNasrin Borumandnia
Nasrin Borumandnia
EKElham Kalhori
Elham Kalhori
MTMahshid Taheri
Mahshid Taheri
NKNahid Khodakarami
Nahid Khodakarami
Background: The acute respiratory disease caused by the coronavirus (COVID-19) has spread rapidly worldwide yet has not been eliminated. The infection is especially deadly in vulnerable populations. The current studies indicate that pregnant women are at greater risk of getting seriously ill. Even though fetuses protect against disease, the additional finding showed that the COVID-19 pandemic could increase fetal and maternal morbidities. In a situation where COVID-19 and new strains of the virus are still not controlled, scientists predicted that the world might experience another pandemic. Consequently, more research about the effects of COVID-19 infection on pregnancy outcomes is needed. This study aimed to compare the pregnancy outcomes of Iranian pregnant women in the first year of the pandemic with the previous year. Methods: This prospective cross-sectional study was performed to compare the pregnancy outcome during the COVID-19 pandemic among Iranian pregnant women who gave birth during the pandemic and one year before the pandemic (2019–2020 and 2020–2021). The sample size was 2,371,332 births registered at hospitals and birth centers platforms. The studied variables include stillbirth, congenital anomaly, birth weight, preeclampsia, gestational diabetes, cesarean section, ICU admission, mean of the gestational age at birth, preterm births, NICU admission, neonatal mortality and the percentage of deliveries with at least one complication such as blood transfusion and postpartum ICU admission. Analyzing data was done by using SPSS version 25 software. Results: We found statistical differences between pregnancy and birth outcomes during the COVID-19 pandemic compared to one year before. The risk of preeclampsia, gestational diabetes, cesarean section, preterm birth and NICU admission were clinically significant. Also, there was a significant decrease in mean gestational age. Conclusion: The COVID-19 pandemic has affected the pregnancy outcome by increasing morbidities and complications during pregnancy, birth, and postpartum. In addition, extensive quarantine outbreaks disrupted the healthcare system and hindered access to prenatal services. It is necessary to develop preventive and therapeutic care protocols for similar pandemic conditions.

28 December 2010 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
NKNahid Khodakarami
Nahid Khodakarami
FFFarah Farzaneh
Farah Farzaneh
FAFatemeh Aslani
Fatemeh Aslani
KAKamyab Alizadeh
Kamyab Alizadeh

5 April 2013 in Iranian Red Crescent Medical Journal
Verified
Journal Article
Open access
PDF file
STShahnaz Torkzahrani
Shahnaz Torkzahrani
LRLeila Rastegari
Leila Rastegari
NKNahid Khodakarami
Nahid Khodakarami
AAAlireza Akbarzadeh-Baghian
Alireza Akbarzadeh-Baghian
KAKamyab Alizadeh
Kamyab Alizadeh
Background: Cervical cancer is the main cause of malignancy-related death among women living in developing countries Objective: The aim of this study is to evaluate the quality of life (QOL) among Iranian cervical cancer survivors and its relationships with demographic and disease related factors. Patients and Methods: A descriptive correlational study was carried out on 65 consecutive cervical cancer survivors in three different oncology centers related to Shahid Beheshti University of Medical Sciences, Tehran. The QOL was evaluated using three different standard questionnaires: 1) EORTC QLQ-C30 for patients with malignant tumors; 2) EORTC QLQ-CX24 for cervical cancer patients; and 3) SSQ for assessing the social support. The data was obtained by telephone interviews. The test-retest reliability and internal consistency of the scales were examined. Cronbach's alpha was calculated to assess internal consistency among items. Content validity was assessed to review the scales. Results: Cervical cancer survivors stated a good QOL. However, its score was negatively associated with symptoms including short breathing, lack of appetite, nausea and vomiting, sleep disorders, peripheral neuropathy, and menopausal symptoms. Also, there was a positive association between QOL and economic conditions as well as QOL and social functioning. Conclusions: Although, the QOL in cervical cancer survivors was good, treatment of related symptoms can influence the QOL and improve the care of these patients. Keywords: Uterine Cervical Neoplasms; Quality of Life; Questionnaires